Your browser doesn't support javascript.
loading
Reduction of brain kynurenic acid improves cognitive function.
Kozak, Rouba; Campbell, Brian M; Strick, Christine A; Horner, Weldon; Hoffmann, William E; Kiss, Tamas; Chapin, Douglas S; McGinnis, Dina; Abbott, Amanda L; Roberts, Brooke M; Fonseca, Kari; Guanowsky, Victor; Young, Damon A; Seymour, Patricia A; Dounay, Amy; Hajos, Mihaly; Williams, Graham V; Castner, Stacy A.
Afiliación
  • Kozak R; Neuroscience Research Unit, Worldwide Research and Development, Pfizer Inc., Cambridge, Massachusetts 02139, rouba.kozak@pfizer.com.
  • Campbell BM; Lundbeck Research US, Paramus, New Jersey 07652, and.
  • Strick CA; Neuroscience Research Unit, Worldwide Research and Development, Pfizer Inc., Cambridge, Massachusetts 02139.
  • Horner W; Neuroscience Research Unit, Worldwide Research and Development, Pfizer Inc., Cambridge, Massachusetts 02139.
  • Hoffmann WE; Neuroscience Research Unit, Worldwide Research and Development, Pfizer Inc., Cambridge, Massachusetts 02139.
  • Kiss T; Neuroscience Research Unit, Worldwide Research and Development, Pfizer Inc., Cambridge, Massachusetts 02139.
  • Chapin DS; Neuroscience Research Unit, Worldwide Research and Development, Pfizer Inc., Cambridge, Massachusetts 02139.
  • McGinnis D; Neuroscience Research Unit, Worldwide Research and Development, Pfizer Inc., Cambridge, Massachusetts 02139.
  • Abbott AL; Departments of Psychiatry and VA Connecticut Healthcare System, West Haven, Connecticut 06519.
  • Roberts BM; Departments of Psychiatry and VA Connecticut Healthcare System, West Haven, Connecticut 06519.
  • Fonseca K; Department of Pharmacokinetics, Pharmacodynamics and Metabolism, Worldwide Research and Development, Pfizer Inc., Cambridge, Massachusetts 02139.
  • Guanowsky V; Neuroscience Research Unit, Worldwide Research and Development, Pfizer Inc., Cambridge, Massachusetts 02139.
  • Young DA; Neuroscience Research Unit, Worldwide Research and Development, Pfizer Inc., Cambridge, Massachusetts 02139.
  • Seymour PA; Neuroscience Research Unit, Worldwide Research and Development, Pfizer Inc., Cambridge, Massachusetts 02139.
  • Dounay A; Neuroscience Research Unit, Worldwide Research and Development, Pfizer Inc., Cambridge, Massachusetts 02139.
  • Hajos M; Comparative Medicine, Yale School of Medicine, New Haven, Connecticut 06510.
  • Williams GV; Departments of Psychiatry and VA Connecticut Healthcare System, West Haven, Connecticut 06519.
  • Castner SA; Departments of Psychiatry and VA Connecticut Healthcare System, West Haven, Connecticut 06519.
J Neurosci ; 34(32): 10592-602, 2014 Aug 06.
Article en En | MEDLINE | ID: mdl-25100593
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esquizofrenia / Encéfalo / Cognición / Ácido Quinurénico Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: J Neurosci Año: 2014 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esquizofrenia / Encéfalo / Cognición / Ácido Quinurénico Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: J Neurosci Año: 2014 Tipo del documento: Article Pais de publicación: Estados Unidos